In a decisive act of global solidarity, Norway has offered almost a third of its allocation of COVAX vaccines to poorer countries, according to Dag-Inge Ulstein, Norway’s Minister of International Development. Norway has only fully vaccinated about 5% of its population – 260,000 people – and unlike many other European countries, it has not stockpiled […] Continue reading ->
British-Swedish pharma company AstraZeneca may have included outdated information from their COVID-19 vaccine trial, the US National Institute of Allergy and Infectious Diseases (NIAID) said in a statement released Tuesday.  The NIAID, part of the National Institutes of Health, urged AstraZeneca to work with the US  Data Safety and Monitoring Board (DSMB) to review the […] Continue reading ->
In news that should be reassuring for skeptics, the Oxford/AstraZeneca COVID-19 vaccine was found to be 79% effective in preventing symptomatic COVID-19 and 100% effective against severe disease and hospitalization in results of a late-stage clinical trial, published today by the pharma company. What’s more, analysis of safety results by an independent board found no […] Continue reading ->
Previous infection with COVID-19 protects most people against reinfection for over six months, but those over the age of 65 are more likely to get infected again, found a peer reviewed study published in The Lancet.  In the world’s first large-scale study of COVID-19 reinfections, researchers from Denmark, Sweden and the United Kingdom discovered that […] Continue reading ->
The European Medicines Agency’s safety committee (PRAC) on Thursday gave a resounding endorsement of the Oxford/AstraZeneca vaccine against COVID-19, concluding that the vaccine’s benefits vaccine “far outweigh” any risks  –  despite a possible link between some vaccinations and rare cases of blood clotting associated with low levels of blood platelets. The EMA statement followed two […] Continue reading ->
Novavax’s COVID-19 vaccine candidate has an efficacy rate of 96.4% against the original strain of SARS-CoV2. However, the efficacy rate drops up to 55.4% against the new B.1351 variant first identified in South Africa, and also spreading globally.  The pharma company, which has never brought a vaccine to market before, published the data from two […] Continue reading ->
The Brazilian government needs to enforce “serious social measures” to contain the virus before it overwhelms its health facilities, World Health Organization (WHO)  Director-General Dr Tedros Adhanom Ghebreyesus told the body’s weekly COVID-19 briefing. Brazil’s President Jair Bolsanaro continues to downplay the pandemic despite the country reaching its highest death rate in the past week […] Continue reading ->